• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Covance U.K. sites receive Carbon Trust Standard accreditation

Covance U.K. sites receive Carbon Trust Standard accreditation

June 18, 2012
CenterWatch Staff

Covance, a provider of drug development services based in Princeton, N.J., has received Carbon Trust Standard accreditation in the U.K. for its commitment to measuring, managing and reducing energy consumption and carbon emissions. 

Covance, one of only 600 companies in Europe to hold this recognition from the non-profit Carbon Trust, achieved this recognition for its four U.K. sites through a rigorous, independent assessment of Covance’s organizational carbon management practices by the Trust.

“The Carbon Trust Standard recognition affirms our strategy to reduce our carbon footprint on the environment, and with it, our overall energy consumption,” said Lucy Hind, head of facilities at Covance in Harrogate. “We are proud and responsible champions against climate change and will continue to manage our facilities and implement future capital projects and improvements that both reduce emissions and deliver energy savings to our company.”  

Covance’s facilities management practices at its sites in Alnwick, Harrogate, Leeds and Maidenhead, U.K., were integral in reducing emissions and securing the Carbon Trust Standard accreditation. All Covance U.K. sites have rigorous energy reporting, management strategies and policies in place that are guided by a corporate U.K. energy committee and designated “energy champion” representatives at each location.  The company also employs a robust energy communication system across its U.K. sites and has provided comprehensive energy reporting to the U.K. government for the past three years. 

“Covance’s commitment to carbon reduction is an important component of our global business strategy,” said Ann Towler, Covance Process Excellence. “While environmental efficiencies benefit our bottom line, it more importantly benefits our employees, our clients and the entire global community. The Carbon Trust Standard provides an important benchmark that we can improve against for years to come.”

Upcoming Events

  • 12Apr

    The Patient Playbook Webinar Series, Part 3 — Rethinking the Development of Participant-Centric Clinical Trial Technology

  • 25Apr

    Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials

  • 26Apr

    FDA’s New Laws and Regulations: What Drug and Biologics Manufacturers Need to Know

  • 27Apr

    Califf’s FDA, 2023 and Beyond: Key Developments, Insights and Analysis

  • 17May

    2023 WCG Avoca Quality Consortium Summit

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Five Ws

    Consider the Five ‘W’s to Understand Potential Participants

  • QandA-360x240.png

    Perspectives from Smaller-Sized CROs: Q&A with Cheryle Evans

  • White House

    Trial Stakeholders Advise White House on Emergency Research Infrastructure

  • SurveywBlueBackground-360x240.png

    Stress Levels Continue to Climb in Healthcare Workforce, Survey Finds

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing